Screener
XBI vs SPYM
State Street SPDR S&P Biotech ETF vs State Street SPDR Portfolio S&P 500 ETF
Key differences
- SPYM costs 0.33% less per year.
- SPYM is significantly larger than XBI — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, SPYM has delivered higher annualized returns.
Side-by-side comparison
| XBI | SPYM | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.02% |
| Fund size (AUM) | $8.3B | $137.6B |
| Since | 2006 | 2005 |
| Dividend yield | 0.34% | 1.05% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +70.7% | +31.2% |
| CAGR 3Y | +16.6% | +23.1% |
| CAGR 5Y | +1.6% | +14.4% |
| Sharpe 3Y | 0.57 | 1.25 |
| Volatility 1Y | 25.16% | 11.95% |
| Max drawdown | -63.89% | -33.87% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to XBI and SPYM
Explore further